Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$51.6M
Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) General Information
Description
Neoleukin Therapeutics was a biopharmaceutical company that generated immunotherapies using de novo protein design technology. The firm used computational methods to design proteins that demonstrate specific pharmaceutical properties that provide potentially superior therapeutic benefit over native proteins to treat serious diseases, including cancer, inflammatory, and autoimmune disorders.
Contact Information
Corporate Office
- 401 Terry Avenue North
- Seattle, WA 98109
- United States
Corporate Office
- 401 Terry Avenue North
- Seattle, WA 98109
- United States
Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Merger/Acquisition | 08-Aug-2019 | $51.6M | Completed | Generating Revenue | ||
1. Early Stage VC | 08-Feb-2019 | Completed | Generating Revenue |
Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) Former Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
WRF Capital | Venture Capital | Minority |
Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) FAQs
-
Where is Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) headquartered?
Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) is headquartered in Seattle, WA.
-
What industry is Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) in?
Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals)’s primary industry is Drug Discovery.
-
Is Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) a private or public company?
Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) is a Private company.
-
What is the current valuation of Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals)?
The current valuation of Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) is
. -
What is Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals)’s current revenue?
The current revenue for Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) is
. -
How much funding has Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) raised over time?
Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) has raised $800K.
-
Who are Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals)’s investors?
WRF Capital has invested in Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals).
-
When was Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) acquired?
Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) was acquired on 08-Aug-2019.
-
Who acquired Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals)?
Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) was acquired by Neoleukin Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »